Literature DB >> 6201384

Schistosoma mansoni: a diamidinophenylindole probe for in vitro death of schistosomula.

P W Van der Linden, A M Deelder.   

Abstract

The following fluorochromes were studied as probes for discrimination between living and dead Schistosoma mansoni schistosomula: ethidium bromide (EB), propidium iodide (PI), diamidinophenylindole (DAPI), and carboxyfluoresceine diacetate (C-FDA). While schistosomula stained with EB, PI, or C-FDA showed leakage of fluorochrome into the medium, this was not the case with DAPI. Dead schistosomula, which were stained with DAPI, showed an intense blue fluorescence, while living schistosomula were not stained even after prolonged incubation. In addition, the low DAPI concentration (1 microgram/ml) in the medium proved not to be toxic to the schistosomula, nor did it cause any background fluorescence. These properties make DAPI an ideal probe: the viability of S. mansoni schistosomula in cytotoxicity tests can be continuously monitored in tissue culture trays, using an inverted microscope with simultaneous transmitted light and incident fluorescent light illumination.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6201384     DOI: 10.1016/0014-4894(84)90071-7

Source DB:  PubMed          Journal:  Exp Parasitol        ISSN: 0014-4894            Impact factor:   2.011


  2 in total

Review 1.  Mechanically produced schistosomula as a higher-throughput tools for phenotypic pre-screening in drug sensitivity assays: current research and future trends.

Authors:  Emmanuel Mouafo Tekwu; William Kofi Anyan; Daniel Boamah; Kofi Owusu Baffour-Awuah; Stephanie Keyetat Tekwu; Veronique Penlap Beng; Alexander Kwadwo Nyarko; Kwabena Mante Bosompem
Journal:  Biomark Res       Date:  2016-11-22

2.  Fluorescence/luminescence-based markers for the assessment of Schistosoma mansoni schistosomula drug assays.

Authors:  Gordana Panic; Dayana Flores; Katrin Ingram-Sieber; Jennifer Keiser
Journal:  Parasit Vectors       Date:  2015-12-08       Impact factor: 3.876

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.